Highly successful living donor kidney transplantation after conversion to negative of a previously positive flow-cytometry cross-match by pretransplant plasmapheresis

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 643-644

  Thielke, J ^a   DeChristopher, P J ^a   Sankary, H ^a   Oberholzer, J ^a   Testa, G ^a   Benedetti, E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; BONE MARROW TOXICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; DESENSITIZATION; DRUG TOLERABILITY; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL TOXICITY; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 17844390651     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.063     Document Type: Conference Paper

References (5)

1. J.M. Gloor, S.R. DeGoey, A.A. Pineda Overcoming a positive cross-match in living-donor kidney transplantation Am J Transplant 3 2003 1017
2. E.J. Schweitzer, J.S. Wilson, M. Fernandez-Vina A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants Transplantation 70 2000 1531
3. E. Akalin, S. Ames, V. Sehgal Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B cell and flow cytometry T- or B-cell cross-match-positive patients Transplantation 76 2003 1444
4. J.M. Gloor, D.J. Lager, S.B. Moore ABO-incompatible kidney transplantation using both A2 and non-A2 living donors Transplantation 75 2003 971
5. R.A. Montgomery, A.A. Zachary, L.C. Racusen Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 70 2000 887